Lipids and apolipoproteins affect the risk of ST-elevation and non-ST-elevation myocardial infarctions differently in type 1 diabetes: a nationwide finnish cohort study

Cardiovascular Diabetology · Published 2026-08-01 · DOI 10.1186/s12933-026-03315-9

Free full text

Authors (8)

Patrik Smidtslund, Fanny Jansson Sigfrids, Valma Harjutsalo, Ville Thorn, Marja-Riitta Taskinen, Per-Henrik Groop, Lena M Thorn, FinnDiane Study Group

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Smidtslund, P., Sigfrids, F., Harjutsalo, V., et al. (2026). Lipids and apolipoproteins affect the risk of ST-elevation and non-ST-elevation myocardial infarctions differently in type 1 diabetes: a nationwide finnish cohort study. Cardiovascular Diabetology. https://doi.org/10.1186/s12933-026-03315-9

Related articles

• Treatment with dapagliflozin and empagliflozin reduces concentrations of N4-acetylcytidine in plasma, a biomarker associated with vascular damage · Cardiovascular Diabetology · 2026 · Same journal
• Associations of cumulative exposure and dynamic trajectories of the cholesterol–HDL–glucose index and its obesity-related derivatives with cardiovascular disease: a nationwide prospective cohort study · Cardiovascular Diabetology · 2026 · Same journal
• Deep learning analysis of ECGs detects Cardiovascular–Kidney–Metabolic syndrome burden in people with diabetes: a report from the Silesia Diabetes-Heart Project · Cardiovascular Diabetology · 2026 · Same journal
• Predicting all-cause and cardiovascular mortality in hypertensive patients by combining the CHG index and its obesity indicators: a prospective cohort study with survival prediction model · Cardiovascular Diabetology · 2026 · Same journal
• Divergent mitochondrial and fibrotic signatures in atrial fibrillation: insights from organoids and GEO data · Cardiovascular Diabetology · 2026 · Same journal
• STIM1-mediated Treg instability in HFpEF: a new immunological target emerges? · Cardiovascular Diabetology · 2026 · Same journal
• Joint longitudinal trajectories of the triglyceride-glucose index combined with BMI and waist-to-height ratio and incident cardiovascular disease: a prospective cohort study from the English longitudinal study of ageing · Cardiovascular Diabetology · 2026 · Same journal
• Genetically proxied glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor pathway modulation is associated with favorable aging phenotypes: a drug-target Mendelian randomization study · Cardiovascular Diabetology · 2026 · Same journal
• Predictive significance of triglyceride-glucose index in forecasting adverse cardiovascular events among Type 2 diabetes mellitus patients with co-existing metabolic dysfunction-associated steatotic liver disease (MASLD): evidence from two cohort studies · Cardiovascular Diabetology · 2026 · Same journal
• Baseline, repeated-measure burden, and two-time-point patterns of the triglyceride-glucose index-visceral lipid ratio (TyG-VLR) and incident cardiovascular disease in cardiovascular-kidney-metabolic (CKM) syndrome stages 0–3: a longitudinal China Health and Retirement Longitudinal Study (CHARLS) analysis · Cardiovascular Diabetology · 2026 · Same journal